PROFESSIONAL USE POINT OF CARE TESTING (POCT) BLOOD GLUCOSE AND KETONE MONITORING SYSTEMS

The procurement process for Professional Use Point of Care Testing (POCT) Blood Glucose and Ketone Monitoring Systems, initiated by the Regional Business Services Organisation Procurement and Logistics Service (BSO PaLS), is currently at the award stage. This comprehensive tender involves collaboration with multiple health and social care trusts in Northern Ireland, including Belfast, Northern, Southern, South Eastern, and Western Health and Social Care Trusts. The procurement focused on acquiring biochemical analysers, falls under the goods category, and employed an open procurement method.

The most recent contract, valued at £16,932,019.10, was awarded to Roche Diagnostics Ltd and signed on 23rd September 2025. The procurement has involved substantial planning and coordination, including a prior information notice and product awareness sessions to gauge market engagement and readiness. This tender presents substantial opportunities for business growth, particularly for suppliers within the medical equipment and biochemical analyser sectors.

It offers a platform for companies providing cutting-edge point-of-care testing technology and associated products, such as blood-testing reagents and reagent strips, to secure contracts with Northern Ireland’s health trusts. Companies with a strong track record in delivering high-quality and cost-effective medical solutions, as evidenced by the award criteria weighting favouring cost at 60% and quality at 40%, would be well-suited to compete. This procurement initiative underscores a robust demand for innovative solutions capable of supporting efficient and reliable health care services across the region.